Nuvation Bio, NHI, Alexanders Elect Directors at 2025 Annual Meetings

Several companies recently held their 2025 Annual Meetings where key governance decisions were made. Nuvation Bio, a pharmaceutical company, elected Kathryn E. Falberg and Dr. David Hung to its Board and ratified KPMG LLP as its independent auditor, amid ongoing operational challenges reflected in a weak financial health score. National Health Investors Inc. (NHI), a REIT focused on senior housing and medical investments, successfully elected all four director nominees—Robert G. Adams, Robert W. Chapin, Jr., James R. Jobe, and Candice W. Todd—signaling strong shareholder support and a commitment to corporate governance improvements, including board declassification. Alexanders Inc., another REIT, re-elected directors Steven Roth and Wendy A. Silverstein and ratified Deloitte & Touche LLP as its auditor, maintaining a strong dividend track record with an 8.25% yield. NHI also emphasized ongoing dialogue with shareholders and its strategic focus on generating superior returns while cautioning about risks in forward-looking statements. These results collectively highlight continued investor engagement and governance enhancements across sectors.